您当前的位置:
首页 >
文章列表页 >
Pharmaceutical care of a case of hepatitis B virus reactivation induced by iparomlimab and tuvonralimab
更新时间:2025-12-26
    • Pharmaceutical care of a case of hepatitis B virus reactivation induced by iparomlimab and tuvonralimab

    • “In the field of immunotherapy, experts analyzed the cases of hepatitis B virus reactivation caused by epalolito voralimab, revealed the clinical characteristics and potential mechanism of adverse reactions related to inhibitors at immune checkpoints, and provided reference for clinical medication.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 24, Pages: 3113-3117(2025)
    • DOI:10.6039/j.issn.1001-0408.2025.24.17    

      CLC: R969.3;R979.1
    • Received:15 July 2025,

      Revised:2025-10-30,

      Accepted:10 November 2025,

      Published:30 December 2025

    移动端阅览

  • LI Duohui,XU Jingyu,LI Lin,et al.Pharmaceutical care of a case of hepatitis B virus reactivation induced by iparomlimab and tuvonralimab[J].ZHONGGUO YAOFANG,2025,36(24):3113-3117. DOI: 10.6039/j.issn.1001-0408.2025.24.17.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Pharmaceutical care for a patient with visual abnormalities induced by oxaliplatin by clinical pharmacists
Pharmaceutical care for the HIV-negative patient with disseminated Talaromyces marneffei osteomyelitis complicated by pulmonary tuberculosis
Expert consensus on rational medication management of targeted PI3K/Akt/mTOR inhibitors in breast cancer
Individualized treatment and pharmaceutical care for breast cancer complicated with chronic kidney disease
Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after renal transplantation

Related Author

ZHANG Yang
CHEN Shuhe
GAO Yue
ZHANG Qinghua
HE Liting
Writing Group of Expert Consensus on Rational Medication Management of Targeted PI3K/Akt/mTOR Inhibitors in Breast Cancer
任天舒
赵庆春

Related Institution

Hubei Academy of Traditional Chinese Medicine
Dept. of Pharmacy, the Affiliated Hospital of Hubei University of Chinese Medicine
Dept. of Pharmacy, Hubei Provincial Hospital of TCM
Dept. of Pharmacy, Jiangmen Central Hospital
Dept. of Internal Medicine, Zhonggongmiao Community Hospital of Ningbo Yinzhou District No.2 Hospital Medical Community
0